Cargando…

Association between Triglyceride-Glucose Index and Early Neurological Outcomes after Thrombolysis in Patients with Acute Ischemic Stroke

Background: The triglyceride-glucose (TyG) index is a novel biomarker of insulin resistance which might plausibly influence endogenous fibrinolysis and thus early neurological outcomes in patients with acute ischemic stroke (AIS) treated with intravenous thrombolysis using recombinant tissue-plasmin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Baixiang, Lei, Hanhan, Ambler, Gareth, Werring, David J., Fang, Shuangfang, Li, Hangfeng, Chen, Ronghua, Wei, Jin, Chen, Guangliang, Liu, Nan, Du, Houwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219034/
https://www.ncbi.nlm.nih.gov/pubmed/37240578
http://dx.doi.org/10.3390/jcm12103471
_version_ 1785048914217402368
author Zhang, Baixiang
Lei, Hanhan
Ambler, Gareth
Werring, David J.
Fang, Shuangfang
Li, Hangfeng
Chen, Ronghua
Wei, Jin
Chen, Guangliang
Liu, Nan
Du, Houwei
author_facet Zhang, Baixiang
Lei, Hanhan
Ambler, Gareth
Werring, David J.
Fang, Shuangfang
Li, Hangfeng
Chen, Ronghua
Wei, Jin
Chen, Guangliang
Liu, Nan
Du, Houwei
author_sort Zhang, Baixiang
collection PubMed
description Background: The triglyceride-glucose (TyG) index is a novel biomarker of insulin resistance which might plausibly influence endogenous fibrinolysis and thus early neurological outcomes in patients with acute ischemic stroke (AIS) treated with intravenous thrombolysis using recombinant tissue-plasminogen activator. Methods: We included consecutive AIS patients within 4.5 h of symptom onset undergoing intravenous thrombolysis between January 2015 and June 2022 in this multi-center retrospective observational study. Our primary outcome was early neurological deterioration (END), defined as ≥2 (END(2)) or ≥ 4 (END(4)) National Institutes of Health Stroke Scale (NIHSS) score worsening compared to the initial NIHSS score within 24 h of intravenous thrombolysis. Our secondary outcome was early neurological improvement (ENI), defined as a lower NIHSS score at discharge. TyG index was calculated using the log scale of fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2. We evaluated the association of END and ENI with TyG index using a logistic regression model. Results: A total of 676 patients with AIS were evaluated. The median age was 68 (Interquartile range, IQR (60–76) years old), and 432 (63.9%) were males. A total of 89 (13.2%) patients developed END(2), 61 (9.0%) patients developed END(4), and 492 (72.7%) experienced ENI. In multivariable logistic regression analysis, after adjustment for confounding factors, TyG index was significantly associated with increased risks of END(2) (categorical variable, vs. lowest tertile, medium tertile odds ratio [OR] 1.05, 95% confidence interval, CI 0.54–2.02, highest tertile OR 2.94, 95%CI 1.64–5.27, overall p < 0.001) and END(4) (categorical variable, vs. lowest tertile, medium tertile OR 1.21, 95%CI 0.54–2.74, highest tertile OR 3.80, 95%CI 1.85–7.79, overall p < 0.001), and a lower probability of ENI (categorical variable, vs. lowest tertile, medium tertile OR 1.00, 95%CI 0.63–1.58, highest tertile OR 0.59, 95%CI 0.38–0.93, overall p = 0.022). Conclusions: Increasing TyG index was associated with a higher risk of END and a lower probability of ENI in patients with acute ischemic stroke treated with intravenous thrombolysis.
format Online
Article
Text
id pubmed-10219034
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102190342023-05-27 Association between Triglyceride-Glucose Index and Early Neurological Outcomes after Thrombolysis in Patients with Acute Ischemic Stroke Zhang, Baixiang Lei, Hanhan Ambler, Gareth Werring, David J. Fang, Shuangfang Li, Hangfeng Chen, Ronghua Wei, Jin Chen, Guangliang Liu, Nan Du, Houwei J Clin Med Article Background: The triglyceride-glucose (TyG) index is a novel biomarker of insulin resistance which might plausibly influence endogenous fibrinolysis and thus early neurological outcomes in patients with acute ischemic stroke (AIS) treated with intravenous thrombolysis using recombinant tissue-plasminogen activator. Methods: We included consecutive AIS patients within 4.5 h of symptom onset undergoing intravenous thrombolysis between January 2015 and June 2022 in this multi-center retrospective observational study. Our primary outcome was early neurological deterioration (END), defined as ≥2 (END(2)) or ≥ 4 (END(4)) National Institutes of Health Stroke Scale (NIHSS) score worsening compared to the initial NIHSS score within 24 h of intravenous thrombolysis. Our secondary outcome was early neurological improvement (ENI), defined as a lower NIHSS score at discharge. TyG index was calculated using the log scale of fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2. We evaluated the association of END and ENI with TyG index using a logistic regression model. Results: A total of 676 patients with AIS were evaluated. The median age was 68 (Interquartile range, IQR (60–76) years old), and 432 (63.9%) were males. A total of 89 (13.2%) patients developed END(2), 61 (9.0%) patients developed END(4), and 492 (72.7%) experienced ENI. In multivariable logistic regression analysis, after adjustment for confounding factors, TyG index was significantly associated with increased risks of END(2) (categorical variable, vs. lowest tertile, medium tertile odds ratio [OR] 1.05, 95% confidence interval, CI 0.54–2.02, highest tertile OR 2.94, 95%CI 1.64–5.27, overall p < 0.001) and END(4) (categorical variable, vs. lowest tertile, medium tertile OR 1.21, 95%CI 0.54–2.74, highest tertile OR 3.80, 95%CI 1.85–7.79, overall p < 0.001), and a lower probability of ENI (categorical variable, vs. lowest tertile, medium tertile OR 1.00, 95%CI 0.63–1.58, highest tertile OR 0.59, 95%CI 0.38–0.93, overall p = 0.022). Conclusions: Increasing TyG index was associated with a higher risk of END and a lower probability of ENI in patients with acute ischemic stroke treated with intravenous thrombolysis. MDPI 2023-05-15 /pmc/articles/PMC10219034/ /pubmed/37240578 http://dx.doi.org/10.3390/jcm12103471 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zhang, Baixiang
Lei, Hanhan
Ambler, Gareth
Werring, David J.
Fang, Shuangfang
Li, Hangfeng
Chen, Ronghua
Wei, Jin
Chen, Guangliang
Liu, Nan
Du, Houwei
Association between Triglyceride-Glucose Index and Early Neurological Outcomes after Thrombolysis in Patients with Acute Ischemic Stroke
title Association between Triglyceride-Glucose Index and Early Neurological Outcomes after Thrombolysis in Patients with Acute Ischemic Stroke
title_full Association between Triglyceride-Glucose Index and Early Neurological Outcomes after Thrombolysis in Patients with Acute Ischemic Stroke
title_fullStr Association between Triglyceride-Glucose Index and Early Neurological Outcomes after Thrombolysis in Patients with Acute Ischemic Stroke
title_full_unstemmed Association between Triglyceride-Glucose Index and Early Neurological Outcomes after Thrombolysis in Patients with Acute Ischemic Stroke
title_short Association between Triglyceride-Glucose Index and Early Neurological Outcomes after Thrombolysis in Patients with Acute Ischemic Stroke
title_sort association between triglyceride-glucose index and early neurological outcomes after thrombolysis in patients with acute ischemic stroke
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219034/
https://www.ncbi.nlm.nih.gov/pubmed/37240578
http://dx.doi.org/10.3390/jcm12103471
work_keys_str_mv AT zhangbaixiang associationbetweentriglycerideglucoseindexandearlyneurologicaloutcomesafterthrombolysisinpatientswithacuteischemicstroke
AT leihanhan associationbetweentriglycerideglucoseindexandearlyneurologicaloutcomesafterthrombolysisinpatientswithacuteischemicstroke
AT amblergareth associationbetweentriglycerideglucoseindexandearlyneurologicaloutcomesafterthrombolysisinpatientswithacuteischemicstroke
AT werringdavidj associationbetweentriglycerideglucoseindexandearlyneurologicaloutcomesafterthrombolysisinpatientswithacuteischemicstroke
AT fangshuangfang associationbetweentriglycerideglucoseindexandearlyneurologicaloutcomesafterthrombolysisinpatientswithacuteischemicstroke
AT lihangfeng associationbetweentriglycerideglucoseindexandearlyneurologicaloutcomesafterthrombolysisinpatientswithacuteischemicstroke
AT chenronghua associationbetweentriglycerideglucoseindexandearlyneurologicaloutcomesafterthrombolysisinpatientswithacuteischemicstroke
AT weijin associationbetweentriglycerideglucoseindexandearlyneurologicaloutcomesafterthrombolysisinpatientswithacuteischemicstroke
AT chenguangliang associationbetweentriglycerideglucoseindexandearlyneurologicaloutcomesafterthrombolysisinpatientswithacuteischemicstroke
AT liunan associationbetweentriglycerideglucoseindexandearlyneurologicaloutcomesafterthrombolysisinpatientswithacuteischemicstroke
AT duhouwei associationbetweentriglycerideglucoseindexandearlyneurologicaloutcomesafterthrombolysisinpatientswithacuteischemicstroke